Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 9:00 pm Sale | 2026-03-31 | 13G | VIR BIOTECHNOLOGY INC VIR | SB Investment Advisers (UK) Limited | 10,948,093 6.500% | -2,168,884 (-16.53%) | Filing History |
| 2026-04-29 3:50 pm Purchase | 2026-03-31 | 13G | VIR BIOTECHNOLOGY INC VIR | Vanguard Portfolio Management | 9,257,235 5.790% | 9,257,235 (New Position) | Filing History |
| 2026-03-27 1:55 pm Sale | 2026-03-13 | 13G | VIR BIOTECHNOLOGY INC VIR | VANGUARD GROUP INC | 0 0.000% | -12,297,139 (Position Closed) | Filing History |
| 2026-03-03 5:00 pm Sale | 2026-02-27 | 13D | VIR BIOTECHNOLOGY INC VIR | ARCH Venture Fund IX, L.P. | 13,534,704 8.500% | -17,606 (-0.13%) | Filing History |
| 2026-02-17 5:00 pm Sale | 2025-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | SB Investment Advisers (UK) Limited | 13,116,977 9.400% | -3,567,064 (-21.38%) | Filing History |
| 2025-04-28 1:02 pm Sale | 2025-03-31 | 13G | VIR BIOTECHNOLOGY INC VIR | BlackRock, Inc. BLK | 14,826,039 10.800% | -2,038,540 (-12.09%) | Filing History |
| 2024-10-18 12:29 pm Sale | 2024-09-30 | 13G | VIR BIOTECHNOLOGY INC VIR | STATE STREET CORP STT | 5,625,533 4.100% | -1,286,549 (-18.61%) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | VIR BIOTECHNOLOGY INC VIR | VANGUARD GROUP INC | 12,297,139 9.140% | 2,202,638 (+21.82%) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | SB Investment Advisers (UK) Limited | 16,684,041 12.400% | 16,684,041 (New Position) | Filing History |
| 2024-01-24 07:59 am Purchase | 2023-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | STATE STREET CORP STT | 6,912,082 5.140% | 6,912,082 (New Position) | Filing History |
| 2024-01-23 4:14 pm Purchase | 2023-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | BlackRock, Inc. BLK | 16,864,579 12.500% | 2,727,951 (+19.30%) | Filing History |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 20,259,535 15.200% | -2,357,131 (-10.42%) | Filing History |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | VIR BIOTECHNOLOGY INC VIR | VANGUARD GROUP INC | 10,094,501 7.580% | 2,764,370 (+37.71%) | Filing History |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | BlackRock, Inc. BLK | 14,136,628 10.600% | 752,434 (+5.62%) | Filing History |
| 2022-09-13 3:45 pm Sale | 2022-08-12 | 13D | VIR BIOTECHNOLOGY INC VIR | ARCH Venture Fund IX, L.P. | 13,552,310 10.200% | -5,636,784 (-29.37%) | Filing History |
| 2022-09-08 1:43 pm Purchase | 2022-08-31 | 13G | VIR BIOTECHNOLOGY INC VIR | BlackRock, Inc. BLK | 13,384,194 10.100% | 13,384,194 (New Position) | Filing History |
| 2022-05-10 5:05 pm Purchase | 2021-12-20 | 13D | VIR BIOTECHNOLOGY INC VIR | ARCH Venture Fund IX, L.P. | 19,189,094 14.700% | 3,374 (+0.02%) | Filing History |
| 2022-02-14 4:05 pm Sale | 2021-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | SCANGOS GEORGE A | 6,266,581 4.790% | -734,727 (-10.49%) | Filing History |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | VIR BIOTECHNOLOGY INC VIR | Capital International Investors | 5,634,019 4.300% | -5,806,552 (-50.75%) | Filing History |
| 2022-02-10 4:46 pm Purchase | 2021-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | GSK plc | 8,550,954 6.500% | 1,924,927 (+29.05%) | Filing History |